Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
- PMID: 39720605
- PMCID: PMC11665706
- DOI: 10.1016/j.eclinm.2024.102979
Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
Abstract
[This corrects the article DOI: 10.1016/j.eclinm.2024.102679.].
© 2024 The Author(s).
Erratum for
-
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.EClinicalMedicine. 2024 Jun 21;73:102679. doi: 10.1016/j.eclinm.2024.102679. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 39007062 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources